Composition
- Active ingredients
- AMPICILLIN SODIUM EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- AMPICILLIN SODIUM EQ 4GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050072-006 · Discontinued
- AMPICILLIN SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050072-004 · Discontinued
- AMPICILLIN SODIUM EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- AMPICILLIN SODIUM EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050072-005 · Discontinued
- AMPICILLIN SODIUM EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050072-003 · Discontinued
- AMPICILLIN SODIUM EQ 125MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050072-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050072.
At a glance
- Brand name
- Penbritin-S
- Active substance
- ampicillin sodium
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Wyeth Ayerst
- Status
- Discontinued
- FDA approval
- 29 Dec 1966
- Application
- NDA050072-002